Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

被引：0
|
作者：
David R. Coghill
Tobias Banaschewski
Peter Nagy
Isabel Hernández Otero
César Soutullo
Brian Yan
Beatriz Caballero
Alessandro Zuddas
机构：
[1] University of Melbourne,Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences
[2] University of Dundee,Central Institute of Mental Health
[3] Medical Faculty Mannheim,Child and Adolescent Neuropsychiatry Unit, Department of Biomedical Sciences
[4] University of Heidelberg,undefined
[5] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,undefined
[6] University Hospital Virgen de la Victoria,undefined
[7] University of Navarra Clinic,undefined
[8] Shire,undefined
[9] Shire,undefined
[10] University of Cagliari,undefined
来源：
CNS Drugs | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：625 / 638
页数：13
相关论文
共 50 条
  • [1] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [2] Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Otero, I. Hernandez
    Banaschewski, T.
    Johnson, M.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Yan, B.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S130 - S130
  • [3] Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study
    Banaschewski, T.
    Zuddas, A.
    Bliss, C.
    Robertson, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S737 - S737
  • [4] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    David R. Coghill
    Tobias Banaschewski
    Caleb Bliss
    Brigitte Robertson
    Alessandro Zuddas
    CNS Drugs, 2018, 32 : 85 - 95
  • [5] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Tobias Banaschewski
    Mats Johnson
    Peter Nagy
    Isabel Hernández Otero
    César A. Soutullo
    Brian Yan
    Alessandro Zuddas
    David R. Coghill
    CNS Drugs, 2018, 32 : 455 - 467
  • [6] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    Coghill, David R.
    Banaschewski, Tobias
    Bliss, Caleb
    Robertson, Brigitte
    Zuddas, Alessandro
    CNS DRUGS, 2018, 32 (01) : 85 - 95
  • [7] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Johnson, Mats
    Nagy, Peter
    Otero, Isabel Hernandez
    Soutullo, Cesar A.
    Yan, Brian
    Zuddas, Alessandro
    Coghill, David R.
    CNS DRUGS, 2018, 32 (05) : 455 - 467
  • [8] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [9] A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Cutler, Andrew J.
    Saylor, Keith
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Childress, Ann C.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (01) : 11 - 21
  • [10] Efficacy of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label study
    DelBello, M. P.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S368 - S368
12345